High-throughput screening strategy identifies compounds active against antibiotic-resistant bacteria

High-throughput screening strategy identifies compounds active against antibiotic-resistant bacteria
Credit: ©Mary Ann Liebert, Inc., publishers

A new study in which researchers rapidly screened more than 11,000 bioactive molecules for activity against an antibiotic-resistant strain of Klebsiella pneumoniae bacteria identified multiple compounds with potent antimicrobial activity. These active compounds included two existing drugs, azidothymidine, an antiviral used to treat HIV infection, and spectinomycin, an antibacterial agent used to treat gonorrhea, as reported in ASSAY and Drug Development Technologies.

Kenneth Smith and James Kirby, Beth Israel Deaconess Medical Center, Boston, MA, describe a high-throughput screening (HTS) assay they developed that is capable of detecting either the direct antibiotic activity of small molecules or their ability to act as adjunctive treatments by synergistically restoring the effectiveness of an antibiotic drug to which bacteria have developed resistance.

The article "Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae" describes how HTS of large compound libraries could lead to the identification of more effective therapies against intractable and potentially life-threatening infections.

"The paper by Smith and Kirby exemplifies the importance of a carefully designed strategy for HTS and follow-up characterization of active ," says ASSAY and Drug Development Technologies Editor-in-Chief Andrew D. Napper, PhD, Associate Director, Nemours Center for Childhood Cancer Research, Head - High Throughput Screening/Drug Discovery Laboratory, and Senior Research Scientist, Nemours/A.I. duPont Hospital for Children (Wilmington, DE). "By implementing this strategy, these authors efficiently and unequivocally identified compounds with clinically important anti-bacterial activity."


Explore further

Screening method uncovers drugs that may combat deadly antibiotic-resistant bacteria

More information: Kenneth P. Smith et al, Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae, ASSAY and Drug Development Technologies (2016). DOI: 10.1089/adt.2016.701
Citation: High-throughput screening strategy identifies compounds active against antibiotic-resistant bacteria (2016, May 11) retrieved 23 July 2019 from https://phys.org/news/2016-05-high-throughput-screening-strategy-compounds-antibiotic-resistant.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
8 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more